Valley National Advisers Inc Novartis Ag Transaction History

Valley National Advisers Inc

  • $554 Million
  • Q3 2024

A detailed history of Valley National Advisers Inc transactions in Novartis Ag stock. As of the latest transaction made, Valley National Advisers Inc holds 9,837 shares of NVS stock, worth $1.02 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
9,837
Previous 16,794 41.43%
Holding current value
$1.02 Million
Previous $1.79 Million 36.77%
% of portfolio
0.2%
Previous 0.27%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$106.13 - $120.89 $738,346 - $841,031
-6,957 Reduced 41.43%
9,837 $1.13 Million
Q2 2024

Jul 18, 2024
SELL
$92.57 - $107.37 $32,492 - $37,686
-351 Reduced 2.05%
16,794 $1.79 Million
Q1 2024

Apr 19, 2024
SELL
$95.27 - $108.47 $28,962 - $32,974
-304 Reduced 1.74%
17,145 $1.66 Million
Q4 2023

Jan 25, 2024
SELL
$92.27 - $101.54 $64,589 - $71,078
-700 Reduced 3.86%
17,449 $1.76 Million
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $105,908 - $117,535
-1,118 Reduced 5.8%
18,149 $1.85 Million
Q2 2023

Jul 31, 2023
SELL
$92.52 - $104.91 $93,352 - $105,854
-1,009 Reduced 4.98%
19,267 $1.95 Million
Q1 2023

Apr 26, 2023
SELL
$80.03 - $92.81 $38,734 - $44,920
-484 Reduced 2.33%
20,276 $2.04 Million
Q4 2022

Jan 12, 2023
SELL
$75.55 - $92.52 $31,655 - $38,765
-419 Reduced 1.98%
20,760 $1.88 Million
Q3 2022

Nov 08, 2022
SELL
$74.61 - $87.26 $12,385 - $14,485
-166 Reduced 0.78%
21,179 $1.64 Million
Q2 2022

Jul 15, 2022
BUY
$80.52 - $93.75 $16,184 - $18,843
201 Added 0.95%
21,345 $1.8 Million
Q1 2022

May 06, 2022
SELL
$80.11 - $90.62 $5,207 - $5,890
-65 Reduced 0.31%
21,144 $1.86 Million
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $29,807 - $32,960
-374 Reduced 1.73%
21,209 $1.86 Million
Q3 2021

Nov 10, 2021
SELL
$81.78 - $95.14 $7,769 - $9,038
-95 Reduced 0.44%
21,583 $1.77 Million
Q2 2021

Aug 02, 2021
SELL
$85.24 - $94.15 $14,064 - $15,534
-165 Reduced 0.76%
21,678 $1.98 Million
Q1 2021

May 07, 2021
SELL
$83.5 - $98.47 $30,644 - $36,138
-367 Reduced 1.65%
21,843 $1.87 Million
Q4 2020

Feb 11, 2021
SELL
$78.07 - $94.43 $44,890 - $54,297
-575 Reduced 2.52%
22,210 $2.1 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $87,479 - $96,915
-1,065 Reduced 4.47%
22,785 $1.98 Million
Q2 2020

Aug 10, 2020
SELL
$80.93 - $91.1 $88,537 - $99,663
-1,094 Reduced 4.39%
23,850 $2.08 Million
Q1 2020

May 13, 2020
SELL
$70.67 - $99.01 $116,676 - $163,465
-1,651 Reduced 6.21%
24,944 $2.06 Million
Q4 2019

Feb 13, 2020
SELL
$84.35 - $95.37 $590 - $667
-7 Reduced 0.03%
26,595 $2.52 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $8,297 - $9,143
-97 Reduced 0.36%
26,602 $2.31 Million
Q2 2019

Aug 08, 2019
SELL
$75.4 - $92.8 $36,192 - $44,544
-480 Reduced 1.77%
26,699 $2.44 Million
Q1 2019

Apr 26, 2019
SELL
$75.32 - $86.15 $132,111 - $151,107
-1,754 Reduced 6.06%
27,179 $2.61 Million
Q4 2018

Feb 25, 2019
SELL
$73.66 - $82.02 $22,245 - $24,770
-302 Reduced 1.03%
28,933 $2.48 Million
Q3 2018

Nov 08, 2018
SELL
$66.94 - $77.43 $14,860 - $17,189
-222 Reduced 0.75%
29,235 $2.52 Million
Q2 2018

Aug 14, 2018
SELL
$64.91 - $73.36 $27,456 - $31,031
-423 Reduced 1.42%
29,457 $2.23 Million
Q1 2018

Apr 19, 2018
SELL
$70.39 - $84.15 $12,810 - $15,315
-182 Reduced 0.61%
29,880 $2.42 Million
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $41,734 - $44,798
-577 Reduced 1.88%
30,062 $2.52 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $2.27 Million - $2.37 Million
30,639
30,639 $2.63 Million

Others Institutions Holding NVS

# of Institutions
1,431
Shares Held
134M
Call Options Held
1.1M
Put Options Held
1.71M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email